Clinical trial
A Phase 2, Randomized, Placebo Controlled Study to Evaluate the Efficacy, Tolerability and Safety of Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) And Parkinson's Disease (PD) Patients
NCT04044131 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Placebo Controlled Study to Evaluate the Efficacy, Tolerability and Safety of Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) And Parkinson's Disease (PD) Patients
- Lead sponsor
- Istanbul Medipol University Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 2, 2019
- Completion date
- April 20, 2021
- Enrollment
- 120 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.